 Jonathan Samet
Concepts (1003)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Air Pollution | 74 | 2026 | 327 | 11.420 |
Why?
| | Smoking | 108 | 2018 | 1472 | 9.080 |
Why?
| | Air Pollutants | 73 | 2025 | 438 | 7.580 |
Why?
| | Environmental Exposure | 75 | 2026 | 590 | 7.420 |
Why?
| | Tobacco Smoke Pollution | 52 | 2016 | 233 | 7.300 |
Why?
| | Public Health | 54 | 2025 | 566 | 6.990 |
Why?
| | Neoplasms, Radiation-Induced | 33 | 2025 | 99 | 5.910 |
Why?
| | Smoking Prevention | 25 | 2021 | 166 | 5.020 |
Why?
| | Air Pollution, Indoor | 30 | 2024 | 181 | 4.420 |
Why?
| | Lung Neoplasms | 69 | 2026 | 2642 | 4.380 |
Why?
| | Epidemiology | 20 | 2020 | 33 | 4.140 |
Why?
| | Particulate Matter | 37 | 2025 | 347 | 4.080 |
Why?
| | Global Health | 22 | 2020 | 401 | 3.890 |
Why?
| | Tobacco Products | 17 | 2024 | 84 | 3.580 |
Why?
| | Smoking Cessation | 27 | 2021 | 439 | 3.570 |
Why?
| | Tobacco Industry | 19 | 2018 | 25 | 3.560 |
Why?
| | Respiratory Tract Diseases | 30 | 2026 | 175 | 3.470 |
Why?
| | Occupational Exposure | 27 | 2025 | 354 | 3.380 |
Why?
| | Radon | 28 | 2024 | 44 | 3.150 |
Why?
| | Mortality | 31 | 2024 | 376 | 2.980 |
Why?
| | Neoplasms | 35 | 2025 | 2884 | 2.940 |
Why?
| | Environmental Health | 14 | 2021 | 40 | 2.850 |
Why?
| | Occupational Diseases | 19 | 2024 | 165 | 2.710 |
Why?
| | Environmental Monitoring | 28 | 2024 | 378 | 2.480 |
Why?
| | Humans | 448 | 2026 | 144957 | 2.450 |
Why?
| | Uranium | 18 | 2025 | 27 | 2.440 |
Why?
| | Carcinogens | 9 | 2022 | 123 | 2.200 |
Why?
| | Electronic Nicotine Delivery Systems | 15 | 2024 | 108 | 2.160 |
Why?
| | United States | 125 | 2026 | 15988 | 2.040 |
Why?
| | Health Policy | 19 | 2020 | 401 | 1.980 |
Why?
| | Cardiovascular Diseases | 29 | 2017 | 2171 | 1.950 |
Why?
| | Ozone | 11 | 2024 | 132 | 1.850 |
Why?
| | Nuclear Weapons | 2 | 2025 | 7 | 1.790 |
Why?
| | Mining | 18 | 2025 | 36 | 1.760 |
Why?
| | Dronabinol | 3 | 2025 | 247 | 1.620 |
Why?
| | Epidemiologic Methods | 20 | 2012 | 89 | 1.590 |
Why?
| | Risk Assessment | 42 | 2020 | 3676 | 1.470 |
Why?
| | Epidemiologic Studies | 9 | 2024 | 68 | 1.460 |
Why?
| | Research | 13 | 2014 | 431 | 1.430 |
Why?
| | Politics | 7 | 2024 | 97 | 1.410 |
Why?
| | United States Environmental Protection Agency | 10 | 2020 | 28 | 1.400 |
Why?
| | Research Design | 15 | 2025 | 1137 | 1.350 |
Why?
| | History, 20th Century | 15 | 2025 | 325 | 1.350 |
Why?
| | Tobacco Use Disorder | 8 | 2015 | 218 | 1.300 |
Why?
| | Environmental Policy | 3 | 2020 | 6 | 1.280 |
Why?
| | Climate Change | 8 | 2026 | 199 | 1.280 |
Why?
| | Respiration Disorders | 7 | 2022 | 78 | 1.190 |
Why?
| | Biomedical Research | 11 | 2020 | 710 | 1.190 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 10 | 2025 | 923 | 1.160 |
Why?
| | Forecasting | 13 | 2020 | 391 | 1.160 |
Why?
| | Risk Factors | 80 | 2025 | 10792 | 1.120 |
Why?
| | Developing Countries | 7 | 2014 | 318 | 1.110 |
Why?
| | Ventilation | 4 | 2024 | 46 | 1.080 |
Why?
| | Urban Health | 8 | 2014 | 96 | 1.050 |
Why?
| | Cost of Illness | 5 | 2018 | 321 | 1.050 |
Why?
| | Cannabis | 2 | 2025 | 509 | 1.040 |
Why?
| | Lung Diseases | 12 | 2018 | 787 | 1.010 |
Why?
| | Menthol | 5 | 2021 | 12 | 1.000 |
Why?
| | Nicotine | 18 | 2016 | 332 | 1.000 |
Why?
| | Causality | 8 | 2016 | 126 | 1.000 |
Why?
| | Inhalation Exposure | 7 | 2017 | 115 | 0.990 |
Why?
| | Nuclear Warfare | 4 | 2024 | 10 | 0.990 |
Why?
| | Models, Statistical | 17 | 2016 | 682 | 0.980 |
Why?
| | Cohort Studies | 38 | 2025 | 5965 | 0.950 |
Why?
| | Guidelines as Topic | 4 | 2020 | 268 | 0.920 |
Why?
| | International Agencies | 5 | 2022 | 30 | 0.920 |
Why?
| | Cotinine | 10 | 2014 | 79 | 0.910 |
Why?
| | Maternal Exposure | 5 | 2016 | 213 | 0.910 |
Why?
| | Health Status Disparities | 3 | 2019 | 321 | 0.890 |
Why?
| | History, 21st Century | 8 | 2025 | 219 | 0.880 |
Why?
| | Soft Tissue Neoplasms | 4 | 2026 | 127 | 0.850 |
Why?
| | Male | 155 | 2025 | 72406 | 0.850 |
Why?
| | Cell Phone | 3 | 2014 | 82 | 0.850 |
Why?
| | Female | 155 | 2025 | 78376 | 0.850 |
Why?
| | Particle Size | 19 | 2014 | 411 | 0.850 |
Why?
| | Magnetic Resonance Imaging | 10 | 2026 | 3869 | 0.840 |
Why?
| | Tuberculosis | 2 | 2019 | 291 | 0.840 |
Why?
| | Asbestos | 5 | 2019 | 36 | 0.840 |
Why?
| | Government Regulation | 5 | 2017 | 38 | 0.830 |
Why?
| | Vaping | 6 | 2024 | 66 | 0.820 |
Why?
| | Environmental Pollutants | 3 | 2019 | 167 | 0.820 |
Why?
| | Sleep Apnea Syndromes | 6 | 2016 | 97 | 0.810 |
Why?
| | Population Health | 1 | 2024 | 44 | 0.810 |
Why?
| | Cause of Death | 12 | 2016 | 472 | 0.800 |
Why?
| | Adult | 105 | 2025 | 40506 | 0.800 |
Why?
| | Conservation of Natural Resources | 3 | 2020 | 132 | 0.790 |
Why?
| | Health Equity | 3 | 2021 | 129 | 0.770 |
Why?
| | Environmental Pollution | 2 | 2020 | 21 | 0.760 |
Why?
| | Public Policy | 11 | 2015 | 79 | 0.760 |
Why?
| | Aged | 89 | 2025 | 25947 | 0.760 |
Why?
| | Advisory Committees | 4 | 2020 | 230 | 0.750 |
Why?
| | Urban Population | 12 | 2009 | 491 | 0.750 |
Why?
| | Vehicle Emissions | 7 | 2023 | 62 | 0.750 |
Why?
| | Child Health | 1 | 2024 | 157 | 0.740 |
Why?
| | Asthma | 14 | 2014 | 1768 | 0.730 |
Why?
| | Flavoring Agents | 3 | 2016 | 11 | 0.730 |
Why?
| | Incidence | 21 | 2024 | 2883 | 0.700 |
Why?
| | United States Food and Drug Administration | 5 | 2017 | 205 | 0.700 |
Why?
| | Middle Aged | 98 | 2025 | 35928 | 0.680 |
Why?
| | Brachial Plexus Neuropathies | 1 | 2021 | 19 | 0.680 |
Why?
| | Brachial Plexus | 1 | 2021 | 35 | 0.670 |
Why?
| | Abnormalities, Radiation-Induced | 1 | 2020 | 1 | 0.670 |
Why?
| | Leadership | 6 | 2024 | 409 | 0.670 |
Why?
| | Public Health Practice | 3 | 2019 | 63 | 0.670 |
Why?
| | Tobacco Smoking | 1 | 2020 | 26 | 0.660 |
Why?
| | Heart Diseases | 5 | 2013 | 350 | 0.660 |
Why?
| | Anniversaries and Special Events | 1 | 2020 | 16 | 0.650 |
Why?
| | New Mexico | 37 | 2002 | 99 | 0.650 |
Why?
| | Disease | 2 | 2019 | 98 | 0.650 |
Why?
| | Science | 2 | 2022 | 56 | 0.640 |
Why?
| | Social Control, Formal | 1 | 2020 | 10 | 0.630 |
Why?
| | Smokers | 1 | 2020 | 137 | 0.610 |
Why?
| | Research Support as Topic | 6 | 2014 | 80 | 0.610 |
Why?
| | Smoke | 4 | 2020 | 148 | 0.600 |
Why?
| | Health Care Costs | 3 | 2014 | 427 | 0.600 |
Why?
| | Risk | 22 | 2016 | 911 | 0.600 |
Why?
| | Viruses | 1 | 2021 | 165 | 0.600 |
Why?
| | Radiation Exposure | 3 | 2025 | 63 | 0.590 |
Why?
| | Epidemiologists | 1 | 2019 | 5 | 0.590 |
Why?
| | Carcinogens, Environmental | 4 | 2015 | 14 | 0.590 |
Why?
| | Filtration | 3 | 2017 | 70 | 0.580 |
Why?
| | Mexico | 15 | 2019 | 233 | 0.570 |
Why?
| | Morbidity | 7 | 2017 | 323 | 0.560 |
Why?
| | Indians, North American | 14 | 1995 | 647 | 0.560 |
Why?
| | Minority Groups | 4 | 2017 | 282 | 0.550 |
Why?
| | International Cooperation | 10 | 2012 | 198 | 0.550 |
Why?
| | Obesity, Abdominal | 1 | 2018 | 46 | 0.550 |
Why?
| | Professional Competence | 4 | 2019 | 98 | 0.540 |
Why?
| | Chernobyl Nuclear Accident | 1 | 2017 | 5 | 0.540 |
Why?
| | Publications | 2 | 2015 | 48 | 0.540 |
Why?
| | Proportional Hazards Models | 13 | 2025 | 1325 | 0.540 |
Why?
| | Smoke-Free Policy | 2 | 2018 | 13 | 0.530 |
Why?
| | Environmental Illness | 1 | 2017 | 3 | 0.530 |
Why?
| | Respiratory Tract Infections | 6 | 2024 | 398 | 0.530 |
Why?
| | Climate | 5 | 2013 | 89 | 0.520 |
Why?
| | Japan | 6 | 2025 | 143 | 0.510 |
Why?
| | Cyclonic Storms | 1 | 2018 | 39 | 0.510 |
Why?
| | Age Factors | 20 | 2020 | 3335 | 0.510 |
Why?
| | Radiology Information Systems | 3 | 2026 | 35 | 0.510 |
Why?
| | Saliva | 6 | 2014 | 249 | 0.510 |
Why?
| | Biomarkers, Tumor | 4 | 2025 | 1322 | 0.500 |
Why?
| | Air Pollutants, Radioactive | 5 | 2006 | 8 | 0.500 |
Why?
| | Chronic Disease | 4 | 2015 | 1813 | 0.490 |
Why?
| | Harm Reduction | 4 | 2021 | 51 | 0.490 |
Why?
| | Organizational Policy | 2 | 2014 | 76 | 0.490 |
Why?
| | World Health Organization | 7 | 2016 | 105 | 0.480 |
Why?
| | Pandemics | 3 | 2024 | 1695 | 0.480 |
Why?
| | Cities | 6 | 2024 | 143 | 0.480 |
Why?
| | Perinatal Death | 1 | 2016 | 26 | 0.480 |
Why?
| | Evidence-Based Practice | 5 | 2018 | 238 | 0.480 |
Why?
| | Biological Transport, Active | 1 | 2016 | 69 | 0.480 |
Why?
| | Radiation Injuries | 1 | 2017 | 151 | 0.480 |
Why?
| | Nitrogen Dioxide | 7 | 2023 | 47 | 0.480 |
Why?
| | Breast Neoplasms | 12 | 2009 | 2456 | 0.470 |
Why?
| | Prospective Studies | 22 | 2024 | 7997 | 0.470 |
Why?
| | Prevalence | 18 | 2020 | 2836 | 0.470 |
Why?
| | Stillbirth | 1 | 2016 | 77 | 0.460 |
Why?
| | Histiocytosis, Langerhans-Cell | 1 | 2016 | 36 | 0.460 |
Why?
| | Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2019 | 293 | 0.460 |
Why?
| | Hazardous Substances | 4 | 2015 | 16 | 0.460 |
Why?
| | Cigarette Smoking | 4 | 2020 | 99 | 0.460 |
Why?
| | Hospitalization | 9 | 2009 | 2434 | 0.460 |
Why?
| | Population Surveillance | 10 | 2018 | 485 | 0.450 |
Why?
| | Obesity | 7 | 2018 | 3082 | 0.450 |
Why?
| | gamma-Glutamyltransferase | 1 | 2015 | 42 | 0.450 |
Why?
| | Bone Diseases | 1 | 2016 | 61 | 0.450 |
Why?
| | Tobacco Use | 1 | 2016 | 61 | 0.450 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 384 | 0.450 |
Why?
| | Coronavirus Infections | 1 | 2020 | 378 | 0.450 |
Why?
| | Organizations | 1 | 2015 | 27 | 0.440 |
Why?
| | Nicotinic Agonists | 3 | 2013 | 137 | 0.440 |
Why?
| | Time Factors | 31 | 2019 | 7183 | 0.440 |
Why?
| | Dose-Response Relationship, Radiation | 5 | 2011 | 140 | 0.440 |
Why?
| | Body Mass Index | 7 | 2016 | 2438 | 0.440 |
Why?
| | Aged, 80 and over | 25 | 2025 | 8279 | 0.430 |
Why?
| | Republic of Korea | 6 | 2019 | 42 | 0.430 |
Why?
| | Epidemics | 1 | 2016 | 98 | 0.430 |
Why?
| | Social Discrimination | 1 | 2014 | 9 | 0.420 |
Why?
| | Health Services Accessibility | 4 | 2017 | 1099 | 0.420 |
Why?
| | Health Facility Administration | 1 | 2014 | 7 | 0.420 |
Why?
| | Case-Control Studies | 21 | 2016 | 3608 | 0.420 |
Why?
| | Linear Models | 9 | 2018 | 854 | 0.410 |
Why?
| | Alkaloids | 1 | 2014 | 28 | 0.410 |
Why?
| | Data Collection | 9 | 2019 | 635 | 0.410 |
Why?
| | Odds Ratio | 15 | 2019 | 1077 | 0.400 |
Why?
| | Carbon Monoxide | 5 | 2022 | 82 | 0.400 |
Why?
| | Behavior | 1 | 2014 | 91 | 0.400 |
Why?
| | Health Promotion | 6 | 2013 | 774 | 0.400 |
Why?
| | Tuberculosis, Pulmonary | 2 | 2016 | 131 | 0.400 |
Why?
| | Lung | 12 | 2016 | 4109 | 0.390 |
Why?
| | Adolescent Behavior | 4 | 2016 | 501 | 0.390 |
Why?
| | Bronchi | 7 | 2000 | 267 | 0.390 |
Why?
| | Bone Neoplasms | 2 | 2026 | 256 | 0.390 |
Why?
| | Aerosols | 5 | 2021 | 186 | 0.390 |
Why?
| | Vanadium | 7 | 2009 | 10 | 0.390 |
Why?
| | Abortion, Spontaneous | 1 | 2014 | 115 | 0.380 |
Why?
| | Europe | 8 | 2024 | 412 | 0.380 |
Why?
| | Hot Temperature | 3 | 2014 | 407 | 0.380 |
Why?
| | Personnel Selection | 1 | 2014 | 93 | 0.380 |
Why?
| | Sex Distribution | 8 | 2019 | 386 | 0.370 |
Why?
| | Child | 35 | 2025 | 22657 | 0.370 |
Why?
| | Workplace | 5 | 2011 | 274 | 0.370 |
Why?
| | Australia | 6 | 2024 | 286 | 0.370 |
Why?
| | Medicare | 7 | 2012 | 887 | 0.370 |
Why?
| | Preventive Medicine | 1 | 2012 | 39 | 0.370 |
Why?
| | Regression Analysis | 10 | 2018 | 1003 | 0.370 |
Why?
| | Canada | 4 | 2024 | 428 | 0.370 |
Why?
| | Life Expectancy | 1 | 2013 | 72 | 0.360 |
Why?
| | Surveys and Questionnaires | 28 | 2024 | 6053 | 0.360 |
Why?
| | Lead | 6 | 2015 | 70 | 0.360 |
Why?
| | Korea | 6 | 2015 | 18 | 0.360 |
Why?
| | Societies, Medical | 10 | 2026 | 887 | 0.360 |
Why?
| | Child Welfare | 3 | 2004 | 231 | 0.360 |
Why?
| | Adolescent | 40 | 2025 | 22453 | 0.360 |
Why?
| | Exercise | 4 | 2021 | 2201 | 0.360 |
Why?
| | Leukemia, Myeloid, Acute | 1 | 2019 | 683 | 0.350 |
Why?
| | Research Report | 1 | 2012 | 87 | 0.350 |
Why?
| | Diabetes Mellitus | 2 | 2019 | 1098 | 0.350 |
Why?
| | Health Surveys | 9 | 2017 | 518 | 0.350 |
Why?
| | Respiratory Sounds | 4 | 2024 | 105 | 0.350 |
Why?
| | Meningioma | 2 | 2010 | 87 | 0.350 |
Why?
| | Genetic Predisposition to Disease | 5 | 2014 | 2365 | 0.350 |
Why?
| | Data Interpretation, Statistical | 5 | 2008 | 372 | 0.350 |
Why?
| | Adenocarcinoma | 4 | 2017 | 931 | 0.340 |
Why?
| | Miners | 2 | 2022 | 3 | 0.340 |
Why?
| | Coal | 3 | 2022 | 19 | 0.340 |
Why?
| | Drug and Narcotic Control | 1 | 2011 | 24 | 0.340 |
Why?
| | Leukocyte Count | 2 | 2005 | 316 | 0.340 |
Why?
| | Heat Stress Disorders | 2 | 2002 | 84 | 0.330 |
Why?
| | Copying Processes | 1 | 2010 | 1 | 0.330 |
Why?
| | Idiopathic Pulmonary Fibrosis | 2 | 2015 | 691 | 0.330 |
Why?
| | China | 8 | 2012 | 269 | 0.330 |
Why?
| | Americas | 3 | 2019 | 26 | 0.320 |
Why?
| | Veterans Disability Claims | 1 | 2010 | 4 | 0.320 |
Why?
| | Dose-Response Relationship, Drug | 7 | 2016 | 2032 | 0.320 |
Why?
| | Women's Health | 2 | 2010 | 310 | 0.320 |
Why?
| | Wildfires | 2 | 2021 | 42 | 0.320 |
Why?
| | Mass Screening | 1 | 2019 | 1348 | 0.320 |
Why?
| | Congresses as Topic | 5 | 2018 | 221 | 0.320 |
Why?
| | Seasons | 10 | 2021 | 556 | 0.320 |
Why?
| | Brazil | 4 | 2019 | 180 | 0.320 |
Why?
| | Education, Public Health Professional | 2 | 2008 | 10 | 0.310 |
Why?
| | Career Choice | 2 | 2010 | 237 | 0.310 |
Why?
| | September 11 Terrorist Attacks | 2 | 2007 | 31 | 0.310 |
Why?
| | Air Microbiology | 3 | 2024 | 50 | 0.310 |
Why?
| | Young Adult | 21 | 2025 | 14126 | 0.310 |
Why?
| | Product Packaging | 3 | 2020 | 6 | 0.310 |
Why?
| | Health | 4 | 2018 | 81 | 0.300 |
Why?
| | Rural Health | 2 | 2007 | 87 | 0.300 |
Why?
| | Child, Preschool | 19 | 2024 | 11799 | 0.300 |
Why?
| | Carcinogenesis | 2 | 2022 | 229 | 0.300 |
Why?
| | Sex Factors | 14 | 2015 | 2114 | 0.290 |
Why?
| | Cystic Fibrosis | 3 | 2014 | 1158 | 0.290 |
Why?
| | Hair | 6 | 2014 | 88 | 0.290 |
Why?
| | Tobacco, Smokeless | 4 | 2016 | 13 | 0.290 |
Why?
| | Blood Glucose | 4 | 2022 | 2330 | 0.290 |
Why?
| | Deception | 1 | 2008 | 18 | 0.280 |
Why?
| | Housing | 7 | 2011 | 144 | 0.280 |
Why?
| | Expert Testimony | 2 | 2006 | 42 | 0.280 |
Why?
| | Alcohol Drinking | 3 | 2005 | 826 | 0.270 |
Why?
| | Glioma | 2 | 2010 | 426 | 0.270 |
Why?
| | Commerce | 4 | 2021 | 79 | 0.270 |
Why?
| | Effect Modifier, Epidemiologic | 1 | 2007 | 8 | 0.270 |
Why?
| | Spirometry | 4 | 2016 | 231 | 0.260 |
Why?
| | Biomarkers | 10 | 2017 | 4275 | 0.260 |
Why?
| | Air Pollutants, Occupational | 4 | 2008 | 42 | 0.260 |
Why?
| | Information Dissemination | 2 | 2010 | 223 | 0.260 |
Why?
| | Evidence-Based Medicine | 6 | 2014 | 732 | 0.260 |
Why?
| | Diagnosis, Differential | 5 | 2026 | 1495 | 0.260 |
Why?
| | Environment, Controlled | 2 | 2006 | 23 | 0.260 |
Why?
| | Construction Materials | 1 | 2007 | 18 | 0.260 |
Why?
| | Musculoskeletal Diseases | 2 | 2025 | 90 | 0.260 |
Why?
| | Registries | 8 | 2022 | 2385 | 0.250 |
Why?
| | Professional Role | 3 | 2019 | 158 | 0.250 |
Why?
| | Foundations | 3 | 2018 | 27 | 0.250 |
Why?
| | Education | 2 | 2018 | 104 | 0.250 |
Why?
| | Bias | 6 | 2018 | 202 | 0.250 |
Why?
| | Ontario | 3 | 2019 | 96 | 0.250 |
Why?
| | Marketing | 4 | 2021 | 24 | 0.250 |
Why?
| | Growth Disorders | 1 | 2007 | 86 | 0.240 |
Why?
| | Muscle Neoplasms | 1 | 2026 | 9 | 0.240 |
Why?
| | Social Environment | 2 | 2019 | 254 | 0.240 |
Why?
| | Tomography, X-Ray Computed | 2 | 2007 | 2738 | 0.240 |
Why?
| | Academies and Institutes | 4 | 2022 | 60 | 0.240 |
Why?
| | Sarcoma, Small Cell | 1 | 2025 | 2 | 0.240 |
Why?
| | Los Angeles | 4 | 2024 | 76 | 0.240 |
Why?
| | Thymus Neoplasms | 1 | 2026 | 27 | 0.230 |
Why?
| | Radon Daughters | 5 | 2022 | 5 | 0.230 |
Why?
| | Publishing | 2 | 2014 | 114 | 0.230 |
Why?
| | RNA-Binding Protein FUS | 1 | 2025 | 15 | 0.230 |
Why?
| | RNA-Binding Protein EWS | 1 | 2025 | 31 | 0.230 |
Why?
| | Thoracic Neoplasms | 1 | 2026 | 39 | 0.230 |
Why?
| | Neurofibroma, Plexiform | 1 | 2025 | 12 | 0.230 |
Why?
| | National Institutes of Health (U.S.) | 3 | 2018 | 143 | 0.230 |
Why?
| | Metals | 4 | 1999 | 142 | 0.230 |
Why?
| | Teaching | 1 | 2008 | 236 | 0.230 |
Why?
| | Respiratory System | 2 | 2021 | 149 | 0.230 |
Why?
| | Mesothelioma | 1 | 2026 | 49 | 0.230 |
Why?
| | NFATC Transcription Factors | 1 | 2025 | 93 | 0.220 |
Why?
| | Retrospective Studies | 13 | 2025 | 17101 | 0.220 |
Why?
| | Disease Susceptibility | 3 | 2018 | 348 | 0.220 |
Why?
| | Anemia | 1 | 2007 | 188 | 0.220 |
Why?
| | Soft Tissue Infections | 1 | 2025 | 39 | 0.220 |
Why?
| | Neurofibromatosis 1 | 1 | 2025 | 54 | 0.220 |
Why?
| | Food Supply | 1 | 2026 | 90 | 0.220 |
Why?
| | Bayes Theorem | 5 | 2006 | 433 | 0.220 |
Why?
| | Program Evaluation | 3 | 2020 | 949 | 0.220 |
Why?
| | Sacroiliac Joint | 1 | 2025 | 37 | 0.220 |
Why?
| | Epidemiologic Research Design | 3 | 2004 | 29 | 0.220 |
Why?
| | Radiography, Thoracic | 1 | 2006 | 171 | 0.220 |
Why?
| | Infant | 16 | 2016 | 10039 | 0.220 |
Why?
| | Myocardial Infarction | 1 | 2012 | 1209 | 0.210 |
Why?
| | Laryngeal Neoplasms | 2 | 2004 | 35 | 0.210 |
Why?
| | Age Distribution | 5 | 2013 | 403 | 0.210 |
Why?
| | Airports | 1 | 2024 | 3 | 0.210 |
Why?
| | Lactoferrin | 3 | 1999 | 36 | 0.210 |
Why?
| | Health Services Research | 2 | 2014 | 396 | 0.210 |
Why?
| | Mutagens | 1 | 2004 | 26 | 0.210 |
Why?
| | Hepatitis B | 1 | 2004 | 66 | 0.210 |
Why?
| | Infant, Newborn | 15 | 2016 | 6434 | 0.210 |
Why?
| | Health Personnel | 3 | 2022 | 748 | 0.210 |
Why?
| | Radiation, Ionizing | 1 | 2024 | 87 | 0.210 |
Why?
| | Rhinovirus | 1 | 2004 | 57 | 0.200 |
Why?
| | Epidemiological Monitoring | 7 | 2008 | 69 | 0.200 |
Why?
| | Mortality, Premature | 2 | 2024 | 14 | 0.200 |
Why?
| | National Health Programs | 2 | 2019 | 23 | 0.200 |
Why?
| | Cleft Palate | 2 | 2015 | 89 | 0.200 |
Why?
| | Glycerol | 1 | 2024 | 90 | 0.200 |
Why?
| | Cross-Sectional Studies | 18 | 2024 | 5872 | 0.200 |
Why?
| | Oncogene Proteins, Fusion | 1 | 2025 | 211 | 0.200 |
Why?
| | Time | 2 | 2003 | 86 | 0.200 |
Why?
| | Vulnerable Populations | 2 | 2015 | 177 | 0.200 |
Why?
| | Environment Design | 1 | 2003 | 27 | 0.200 |
Why?
| | Medical Marijuana | 1 | 2025 | 123 | 0.200 |
Why?
| | Liability, Legal | 2 | 2006 | 43 | 0.200 |
Why?
| | Sarcoma | 1 | 2026 | 205 | 0.200 |
Why?
| | Osteomyelitis | 1 | 2025 | 143 | 0.200 |
Why?
| | Hypertension | 5 | 2012 | 1264 | 0.200 |
Why?
| | Pregnancy | 11 | 2016 | 7191 | 0.200 |
Why?
| | Logistic Models | 10 | 2016 | 2119 | 0.190 |
Why?
| | Brain Neoplasms | 2 | 2010 | 1322 | 0.190 |
Why?
| | Germ-Line Mutation | 1 | 2004 | 175 | 0.190 |
Why?
| | Fasting | 1 | 2005 | 277 | 0.190 |
Why?
| | Diabetes Complications | 1 | 2005 | 223 | 0.190 |
Why?
| | Dust | 4 | 2007 | 102 | 0.190 |
Why?
| | Sensitivity and Specificity | 4 | 2016 | 1990 | 0.190 |
Why?
| | Travel | 1 | 2004 | 136 | 0.190 |
Why?
| | Weather | 5 | 2009 | 43 | 0.190 |
Why?
| | Medical Oncology | 1 | 2026 | 332 | 0.190 |
Why?
| | Disinfection | 1 | 2024 | 129 | 0.190 |
Why?
| | Databases as Topic | 4 | 2008 | 71 | 0.190 |
Why?
| | Reproducibility of Results | 6 | 2025 | 3415 | 0.180 |
Why?
| | Polonium | 3 | 1991 | 3 | 0.180 |
Why?
| | Electromagnetic Fields | 2 | 2014 | 38 | 0.180 |
Why?
| | Adrenal Cortex Hormones | 1 | 2005 | 479 | 0.180 |
Why?
| | Financial Support | 2 | 2016 | 17 | 0.180 |
Why?
| | California | 5 | 2025 | 475 | 0.180 |
Why?
| | Risk Management | 3 | 2008 | 84 | 0.180 |
Why?
| | Engineering | 1 | 2022 | 30 | 0.180 |
Why?
| | Pfiesteria piscicida | 1 | 2001 | 1 | 0.180 |
Why?
| | Protozoan Infections | 1 | 2001 | 11 | 0.180 |
Why?
| | Nickel | 4 | 2009 | 64 | 0.180 |
Why?
| | Healthcare Disparities | 2 | 2020 | 728 | 0.180 |
Why?
| | Shoulder Joint | 1 | 2024 | 198 | 0.180 |
Why?
| | Recurrence | 2 | 2019 | 1135 | 0.170 |
Why?
| | Analgesics | 1 | 2023 | 231 | 0.170 |
Why?
| | Policy Making | 4 | 2012 | 82 | 0.170 |
Why?
| | Lumbosacral Plexus | 1 | 2021 | 10 | 0.170 |
Why?
| | Baltimore | 5 | 2014 | 71 | 0.170 |
Why?
| | Estrogen Replacement Therapy | 1 | 2002 | 144 | 0.170 |
Why?
| | Gases | 2 | 2007 | 53 | 0.170 |
Why?
| | Pulmonary Fibrosis | 3 | 2000 | 395 | 0.170 |
Why?
| | Plants, Toxic | 2 | 1998 | 18 | 0.170 |
Why?
| | Conflict of Interest | 1 | 2001 | 53 | 0.170 |
Why?
| | Maximum Allowable Concentration | 2 | 2015 | 16 | 0.170 |
Why?
| | Carcinoma, Hepatocellular | 1 | 2004 | 372 | 0.170 |
Why?
| | Hyperglycemia | 1 | 2005 | 375 | 0.170 |
Why?
| | SEER Program | 2 | 2021 | 224 | 0.160 |
Why?
| | Bismuth | 2 | 1991 | 3 | 0.160 |
Why?
| | Residence Characteristics | 4 | 2018 | 378 | 0.160 |
Why?
| | Reproduction | 2 | 2001 | 207 | 0.160 |
Why?
| | Receptors, Cell Surface | 2 | 2001 | 377 | 0.160 |
Why?
| | Extremities | 3 | 2024 | 140 | 0.160 |
Why?
| | Patient Admission | 3 | 2012 | 218 | 0.160 |
Why?
| | Medicine | 1 | 2022 | 125 | 0.160 |
Why?
| | Poisson Distribution | 3 | 2012 | 78 | 0.160 |
Why?
| | Algorithms | 6 | 2026 | 1839 | 0.160 |
Why?
| | Confidentiality | 2 | 2019 | 79 | 0.160 |
Why?
| | Social Determinants of Health | 1 | 2024 | 301 | 0.150 |
Why?
| | Health Priorities | 4 | 2010 | 42 | 0.150 |
Why?
| | Clinical Medicine | 1 | 2000 | 26 | 0.150 |
Why?
| | Competency-Based Education | 1 | 2020 | 79 | 0.150 |
Why?
| | Arachidonic Acid | 3 | 2001 | 101 | 0.150 |
Why?
| | Follow-Up Studies | 10 | 2020 | 5417 | 0.150 |
Why?
| | Minnesota | 3 | 2009 | 169 | 0.150 |
Why?
| | Panama | 1 | 2019 | 14 | 0.150 |
Why?
| | Anti-Inflammatory Agents | 1 | 2003 | 475 | 0.150 |
Why?
| | Carbon | 5 | 2009 | 203 | 0.150 |
Why?
| | Talc | 1 | 2019 | 9 | 0.150 |
Why?
| | Petroleum Pollution | 1 | 2019 | 10 | 0.150 |
Why?
| | Public Health Surveillance | 1 | 2020 | 83 | 0.150 |
Why?
| | Biodiversity | 1 | 2023 | 426 | 0.150 |
Why?
| | Models, Theoretical | 5 | 2014 | 582 | 0.150 |
Why?
| | Mast Cells | 2 | 2001 | 146 | 0.150 |
Why?
| | Policy | 2 | 2021 | 147 | 0.150 |
Why?
| | Animals | 18 | 2020 | 38109 | 0.150 |
Why?
| | Licensure | 1 | 2019 | 16 | 0.150 |
Why?
| | Peripheral Nerve Injuries | 1 | 2019 | 38 | 0.140 |
Why?
| | Artificial Intelligence | 1 | 2023 | 367 | 0.140 |
Why?
| | Ethiopia | 3 | 2026 | 44 | 0.140 |
Why?
| | Authorship | 1 | 1999 | 49 | 0.140 |
Why?
| | Arsenic | 1 | 1999 | 66 | 0.140 |
Why?
| | Catholicism | 1 | 2018 | 9 | 0.140 |
Why?
| | Molecular Epidemiology | 2 | 2009 | 73 | 0.140 |
Why?
| | Disasters | 3 | 2018 | 102 | 0.140 |
Why?
| | Mental Health | 1 | 2025 | 792 | 0.140 |
Why?
| | Weight Gain | 1 | 2002 | 559 | 0.140 |
Why?
| | Human Migration | 1 | 2018 | 26 | 0.140 |
Why?
| | Social Responsibility | 1 | 2018 | 55 | 0.140 |
Why?
| | Greenhouse Gases | 1 | 2018 | 8 | 0.140 |
Why?
| | Transferrin | 1 | 1998 | 50 | 0.140 |
Why?
| | HIV Infections | 5 | 2016 | 3154 | 0.140 |
Why?
| | Protein Tyrosine Phosphatases | 1 | 1999 | 168 | 0.140 |
Why?
| | Glycine | 1 | 2019 | 187 | 0.140 |
Why?
| | Writing | 1 | 1999 | 100 | 0.140 |
Why?
| | Liver Neoplasms | 1 | 2004 | 783 | 0.140 |
Why?
| | Frail Elderly | 1 | 1999 | 134 | 0.140 |
Why?
| | Emergency Service, Hospital | 2 | 2009 | 2313 | 0.140 |
Why?
| | Radiobiology | 1 | 2017 | 7 | 0.140 |
Why?
| | Health Communication | 1 | 2018 | 54 | 0.140 |
Why?
| | Models, Biological | 4 | 2015 | 1822 | 0.140 |
Why?
| | Restaurants | 3 | 2012 | 22 | 0.130 |
Why?
| | Poverty | 3 | 2023 | 530 | 0.130 |
Why?
| | Veterans | 1 | 2010 | 1603 | 0.130 |
Why?
| | Antioxidants | 1 | 2001 | 549 | 0.130 |
Why?
| | Cross-Over Studies | 4 | 2022 | 601 | 0.130 |
Why?
| | Ferritins | 4 | 1998 | 69 | 0.130 |
Why?
| | Industry | 2 | 2010 | 43 | 0.130 |
Why?
| | Sleep | 3 | 2018 | 901 | 0.130 |
Why?
| | Cross-Cultural Comparison | 3 | 1994 | 84 | 0.130 |
Why?
| | Heating | 3 | 2007 | 18 | 0.130 |
Why?
| | Betacoronavirus | 1 | 2020 | 286 | 0.130 |
Why?
| | Bronchitis, Chronic | 1 | 2017 | 16 | 0.130 |
Why?
| | Pulmonary Medicine | 2 | 2017 | 79 | 0.130 |
Why?
| | Air | 2 | 2010 | 45 | 0.130 |
Why?
| | Economics | 1 | 2017 | 10 | 0.130 |
Why?
| | Public Health Administration | 1 | 2018 | 73 | 0.130 |
Why?
| | Imaging, Three-Dimensional | 1 | 2021 | 583 | 0.130 |
Why?
| | Diabetes Mellitus, Type 2 | 2 | 2022 | 2584 | 0.130 |
Why?
| | Environment | 2 | 2012 | 305 | 0.130 |
Why?
| | Publication Bias | 2 | 2008 | 17 | 0.130 |
Why?
| | Universities | 2 | 2016 | 452 | 0.130 |
Why?
| | Social Class | 3 | 2017 | 268 | 0.120 |
Why?
| | Periodicals as Topic | 1 | 1999 | 203 | 0.120 |
Why?
| | Radiation Dosage | 4 | 2007 | 193 | 0.120 |
Why?
| | Occupational Health | 1 | 1999 | 209 | 0.120 |
Why?
| | Dioxins | 1 | 1996 | 7 | 0.120 |
Why?
| | Stem Cell Factor | 1 | 1996 | 17 | 0.120 |
Why?
| | Ferric Compounds | 1 | 1997 | 55 | 0.120 |
Why?
| | Iran | 1 | 2016 | 44 | 0.120 |
Why?
| | Zinc | 1 | 1999 | 295 | 0.120 |
Why?
| | North America | 4 | 2021 | 310 | 0.120 |
Why?
| | Peer Influence | 1 | 2016 | 14 | 0.120 |
Why?
| | Product Labeling | 1 | 2016 | 11 | 0.120 |
Why?
| | Mental Disorders | 1 | 2025 | 1172 | 0.120 |
Why?
| | Eating | 1 | 2018 | 392 | 0.120 |
Why?
| | Xenobiotics | 1 | 1995 | 32 | 0.120 |
Why?
| | Polycyclic Aromatic Hydrocarbons | 2 | 2007 | 29 | 0.120 |
Why?
| | Capacity Building | 1 | 2016 | 62 | 0.120 |
Why?
| | Emigrants and Immigrants | 1 | 2018 | 158 | 0.110 |
Why?
| | Socioeconomic Factors | 5 | 2016 | 1327 | 0.110 |
Why?
| | Air Pollution, Radioactive | 1 | 1994 | 3 | 0.110 |
Why?
| | Asia | 4 | 2024 | 70 | 0.110 |
Why?
| | Polychlorinated Dibenzodioxins | 2 | 2010 | 10 | 0.110 |
Why?
| | Coinfection | 1 | 2016 | 141 | 0.110 |
Why?
| | Internationality | 1 | 2016 | 156 | 0.110 |
Why?
| | Sleep Apnea, Obstructive | 2 | 2014 | 300 | 0.110 |
Why?
| | Schools, Medical | 1 | 2016 | 157 | 0.110 |
Why?
| | Primary Health Care | 1 | 2005 | 1734 | 0.110 |
Why?
| | Cooking | 2 | 2023 | 67 | 0.110 |
Why?
| | Motivation | 1 | 2020 | 610 | 0.110 |
Why?
| | Radiation Effects | 2 | 2004 | 7 | 0.110 |
Why?
| | Insurance, Health | 2 | 2009 | 303 | 0.110 |
Why?
| | Prognosis | 7 | 2025 | 4293 | 0.110 |
Why?
| | Oxidants | 1 | 1994 | 103 | 0.110 |
Why?
| | Latin America | 1 | 2014 | 94 | 0.100 |
Why?
| | PubMed | 1 | 2014 | 15 | 0.100 |
Why?
| | Review Literature as Topic | 1 | 2014 | 53 | 0.100 |
Why?
| | Mastectomy, Segmental | 1 | 1994 | 108 | 0.100 |
Why?
| | Mucus | 1 | 1994 | 73 | 0.100 |
Why?
| | Silicosis | 1 | 1994 | 30 | 0.100 |
Why?
| | Ganglionic Stimulants | 2 | 2015 | 15 | 0.100 |
Why?
| | Pelvic Bones | 1 | 2016 | 135 | 0.100 |
Why?
| | Cleft Lip | 1 | 2014 | 72 | 0.100 |
Why?
| | Temperature | 5 | 2005 | 679 | 0.100 |
Why?
| | Drug Synergism | 1 | 2014 | 357 | 0.100 |
Why?
| | Health Plan Implementation | 1 | 2014 | 136 | 0.100 |
Why?
| | Breast | 1 | 1994 | 159 | 0.100 |
Why?
| | Analysis of Variance | 4 | 2009 | 1311 | 0.100 |
Why?
| | Community Networks | 1 | 2013 | 57 | 0.100 |
Why?
| | Benzene | 2 | 2023 | 18 | 0.100 |
Why?
| | Bone and Bones | 1 | 2016 | 315 | 0.100 |
Why?
| | Taxes | 2 | 2010 | 16 | 0.100 |
Why?
| | History, 19th Century | 1 | 2013 | 62 | 0.100 |
Why?
| | Greenhouse Effect | 3 | 2001 | 10 | 0.090 |
Why?
| | American Cancer Society | 2 | 2009 | 5 | 0.090 |
Why?
| | Administration, Inhalation | 2 | 2005 | 575 | 0.090 |
Why?
| | Zonula Occludens-1 Protein | 1 | 2012 | 16 | 0.090 |
Why?
| | Names | 1 | 2012 | 15 | 0.090 |
Why?
| | Apoptosis Regulatory Proteins | 2 | 2024 | 187 | 0.090 |
Why?
| | Iron | 4 | 1999 | 359 | 0.090 |
Why?
| | Snoring | 2 | 2010 | 18 | 0.090 |
Why?
| | Local Government | 1 | 2012 | 27 | 0.090 |
Why?
| | Calpain | 1 | 2012 | 61 | 0.090 |
Why?
| | Allergens | 2 | 2014 | 384 | 0.090 |
Why?
| | Program Development | 1 | 2014 | 370 | 0.090 |
Why?
| | Sodium, Dietary | 1 | 2012 | 37 | 0.090 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 1 | 2021 | 1182 | 0.090 |
Why?
| | Inflammation | 4 | 2023 | 2880 | 0.090 |
Why?
| | United Kingdom | 2 | 2006 | 338 | 0.090 |
Why?
| | Nonlinear Dynamics | 2 | 2003 | 95 | 0.090 |
Why?
| | TRPM Cation Channels | 1 | 2012 | 75 | 0.090 |
Why?
| | Feeding Behavior | 1 | 1998 | 685 | 0.090 |
Why?
| | Sampling Studies | 2 | 2006 | 99 | 0.090 |
Why?
| | Diet, Carbohydrate-Restricted | 2 | 2022 | 37 | 0.090 |
Why?
| | Public Facilities | 2 | 2008 | 4 | 0.090 |
Why?
| | Eosinophils | 1 | 2014 | 316 | 0.090 |
Why?
| | Maryland | 2 | 2008 | 66 | 0.090 |
Why?
| | Pennsylvania | 5 | 2006 | 138 | 0.090 |
Why?
| | Sick Building Syndrome | 1 | 2011 | 4 | 0.080 |
Why?
| | Students, Medical | 1 | 2016 | 375 | 0.080 |
Why?
| | Body Temperature | 2 | 2002 | 229 | 0.080 |
Why?
| | Communicable Diseases | 2 | 2011 | 163 | 0.080 |
Why?
| | Crime | 1 | 2011 | 60 | 0.080 |
Why?
| | Printing | 1 | 2010 | 5 | 0.080 |
Why?
| | Manufactured Materials | 1 | 2010 | 8 | 0.080 |
Why?
| | Self Report | 4 | 2017 | 873 | 0.080 |
Why?
| | Cell Line, Transformed | 3 | 1999 | 140 | 0.080 |
Why?
| | Pregnancy, Ectopic | 1 | 1991 | 53 | 0.080 |
Why?
| | Health Education | 4 | 2014 | 358 | 0.080 |
Why?
| | Defoliants, Chemical | 1 | 2010 | 2 | 0.080 |
Why?
| | Agent Orange | 1 | 2010 | 3 | 0.080 |
Why?
| | 2,4,5-Trichlorophenoxyacetic Acid | 1 | 2010 | 3 | 0.080 |
Why?
| | Prostatic Neoplasms | 3 | 1996 | 978 | 0.080 |
Why?
| | Maternal Welfare | 1 | 2010 | 21 | 0.080 |
Why?
| | 2,4-Dichlorophenoxyacetic Acid | 1 | 2010 | 14 | 0.080 |
Why?
| | Aging | 2 | 2002 | 1966 | 0.080 |
Why?
| | Lung Diseases, Obstructive | 2 | 1988 | 43 | 0.080 |
Why?
| | Waist Circumference | 1 | 2010 | 139 | 0.080 |
Why?
| | New York City | 2 | 2007 | 89 | 0.080 |
Why?
| | Water Pollution | 2 | 2018 | 9 | 0.080 |
Why?
| | Developed Countries | 1 | 2010 | 38 | 0.080 |
Why?
| | Disclosure | 1 | 2010 | 85 | 0.080 |
Why?
| | Curriculum | 2 | 2008 | 1060 | 0.080 |
Why?
| | Suicide | 1 | 2017 | 720 | 0.080 |
Why?
| | Legislation as Topic | 1 | 2009 | 5 | 0.080 |
Why?
| | Carcinoma | 2 | 2007 | 228 | 0.080 |
Why?
| | Legislation, Medical | 1 | 2009 | 11 | 0.080 |
Why?
| | Radioactive Pollutants | 1 | 1989 | 1 | 0.080 |
Why?
| | Medical Record Linkage | 2 | 2013 | 68 | 0.080 |
Why?
| | Monte Carlo Method | 1 | 2009 | 155 | 0.070 |
Why?
| | Food Contamination, Radioactive | 1 | 1989 | 1 | 0.070 |
Why?
| | Birth Weight | 1 | 2012 | 522 | 0.070 |
Why?
| | Models, Econometric | 1 | 2009 | 34 | 0.070 |
Why?
| | Cooperative Behavior | 2 | 2018 | 465 | 0.070 |
Why?
| | Radioisotopes | 1 | 1989 | 37 | 0.070 |
Why?
| | Survival Rate | 5 | 2009 | 2092 | 0.070 |
Why?
| | Costs and Cost Analysis | 1 | 2010 | 220 | 0.070 |
Why?
| | Gallbladder Diseases | 1 | 1988 | 11 | 0.070 |
Why?
| | Phospholipases A | 2 | 2001 | 98 | 0.070 |
Why?
| | Gas Chromatography-Mass Spectrometry | 1 | 2009 | 131 | 0.070 |
Why?
| | New York | 2 | 2010 | 127 | 0.070 |
Why?
| | ROC Curve | 1 | 2010 | 615 | 0.070 |
Why?
| | Nicotinic Antagonists | 1 | 2008 | 37 | 0.070 |
Why?
| | Epithelial Cells | 6 | 2000 | 1126 | 0.070 |
Why?
| | Decision Making | 3 | 2010 | 980 | 0.070 |
Why?
| | Interdisciplinary Communication | 2 | 2011 | 197 | 0.070 |
Why?
| | Students, Public Health | 1 | 2008 | 1 | 0.070 |
Why?
| | Computer Simulation | 2 | 2009 | 1026 | 0.070 |
Why?
| | DNA Damage | 2 | 2004 | 430 | 0.070 |
Why?
| | Dyspnea | 3 | 2024 | 251 | 0.070 |
Why?
| | Nutrition Surveys | 2 | 2012 | 282 | 0.070 |
Why?
| | Cells, Cultured | 6 | 2012 | 4155 | 0.070 |
Why?
| | Epidemiologic Factors | 2 | 2002 | 10 | 0.070 |
Why?
| | Bronchial Hyperreactivity | 1 | 2008 | 96 | 0.070 |
Why?
| | Signal Transduction | 3 | 2003 | 5233 | 0.070 |
Why?
| | Bone Marrow Cells | 2 | 2001 | 320 | 0.070 |
Why?
| | Pregnancy Outcome | 1 | 1991 | 476 | 0.070 |
Why?
| | Spectroscopy, Fourier Transform Infrared | 1 | 2007 | 88 | 0.070 |
Why?
| | Coal Ash | 4 | 2000 | 8 | 0.070 |
Why?
| | Rescue Work | 1 | 2007 | 12 | 0.060 |
Why?
| | Financing, Government | 2 | 2004 | 53 | 0.060 |
Why?
| | Cardiovascular System | 1 | 2009 | 138 | 0.060 |
Why?
| | Polysomnography | 5 | 2009 | 235 | 0.060 |
Why?
| | Menopause | 2 | 2002 | 320 | 0.060 |
Why?
| | Predictive Value of Tests | 3 | 2010 | 2118 | 0.060 |
Why?
| | Agriculture | 2 | 2026 | 104 | 0.060 |
Why?
| | Delivery of Health Care | 1 | 2014 | 947 | 0.060 |
Why?
| | Automobile Driving | 1 | 2009 | 157 | 0.060 |
Why?
| | Insurance Coverage | 1 | 2009 | 239 | 0.060 |
Why?
| | Overweight | 2 | 2016 | 609 | 0.060 |
Why?
| | Genome-Wide Association Study | 2 | 2014 | 1407 | 0.060 |
Why?
| | Tars | 1 | 2006 | 5 | 0.060 |
Why?
| | Schools, Public Health | 1 | 2006 | 4 | 0.060 |
Why?
| | Forced Expiratory Volume | 3 | 2016 | 449 | 0.060 |
Why?
| | Poland | 1 | 2006 | 34 | 0.060 |
Why?
| | Chromatography, Gas | 1 | 2006 | 32 | 0.060 |
Why?
| | Energy Intake | 2 | 2001 | 500 | 0.060 |
Why?
| | Multivariate Analysis | 5 | 2009 | 1540 | 0.060 |
Why?
| | Cost-Benefit Analysis | 1 | 2009 | 636 | 0.060 |
Why?
| | NF-kappa B | 3 | 2001 | 662 | 0.060 |
Why?
| | Geography | 2 | 2008 | 203 | 0.060 |
Why?
| | Quality Improvement | 1 | 2015 | 1291 | 0.060 |
Why?
| | Biomass | 1 | 2007 | 116 | 0.060 |
Why?
| | Survival Analysis | 2 | 2004 | 1385 | 0.060 |
Why?
| | Sulfur Dioxide | 4 | 2001 | 13 | 0.060 |
Why?
| | Cattle | 1 | 1989 | 1000 | 0.060 |
Why?
| | Practice Guidelines as Topic | 3 | 2017 | 1563 | 0.060 |
Why?
| | Single Person | 1 | 1986 | 6 | 0.060 |
Why?
| | Statistics, Nonparametric | 2 | 2009 | 427 | 0.060 |
Why?
| | Africa, Eastern | 1 | 2026 | 12 | 0.060 |
Why?
| | Consensus | 1 | 2008 | 489 | 0.060 |
Why?
| | Fires | 1 | 2007 | 87 | 0.060 |
Why?
| | Cough | 1 | 2007 | 124 | 0.060 |
Why?
| | Population Growth | 1 | 2026 | 12 | 0.060 |
Why?
| | Gift Giving | 1 | 2006 | 9 | 0.060 |
Why?
| | Sleep Stages | 1 | 2006 | 75 | 0.060 |
Why?
| | ErbB Receptors | 1 | 2009 | 629 | 0.060 |
Why?
| | Models, Educational | 1 | 2006 | 89 | 0.060 |
Why?
| | Computer-Assisted Instruction | 1 | 2006 | 71 | 0.060 |
Why?
| | Students | 3 | 2016 | 663 | 0.060 |
Why?
| | Edible Grain | 1 | 2026 | 49 | 0.060 |
Why?
| | Thinness | 1 | 2006 | 99 | 0.060 |
Why?
| | Health Status | 2 | 2020 | 836 | 0.060 |
Why?
| | Meta-Analysis as Topic | 1 | 2006 | 174 | 0.060 |
Why?
| | Interinstitutional Relations | 1 | 2006 | 53 | 0.060 |
Why?
| | Bioterrorism | 1 | 2006 | 31 | 0.060 |
Why?
| | Peripheral Arterial Disease | 1 | 2012 | 503 | 0.060 |
Why?
| | Biological Specimen Banks | 1 | 2006 | 103 | 0.060 |
Why?
| | Endothelium, Vascular | 1 | 2012 | 965 | 0.060 |
Why?
| | Behavior, Addictive | 1 | 2006 | 88 | 0.060 |
Why?
| | Education, Distance | 1 | 2006 | 61 | 0.060 |
Why?
| | United States Department of Veterans Affairs | 1 | 2010 | 768 | 0.060 |
Why?
| | Rats | 4 | 1998 | 5614 | 0.060 |
Why?
| | Communicable Disease Control | 1 | 2006 | 86 | 0.060 |
Why?
| | Goals | 1 | 2007 | 184 | 0.060 |
Why?
| | Hepatitis B Surface Antigens | 1 | 2004 | 17 | 0.060 |
Why?
| | Interviews as Topic | 4 | 2010 | 901 | 0.050 |
Why?
| | Deferoxamine | 3 | 1999 | 27 | 0.050 |
Why?
| | Mexican Americans | 2 | 2018 | 114 | 0.050 |
Why?
| | Immunohistochemistry | 2 | 1999 | 1718 | 0.050 |
Why?
| | Financing, Organized | 1 | 2004 | 36 | 0.050 |
Why?
| | Uruguay | 1 | 2004 | 2 | 0.050 |
Why?
| | Paraguay | 1 | 2004 | 3 | 0.050 |
Why?
| | Longitudinal Studies | 3 | 2016 | 2947 | 0.050 |
Why?
| | Disaster Planning | 1 | 2006 | 102 | 0.050 |
Why?
| | Glomerular Filtration Rate | 1 | 2008 | 760 | 0.050 |
Why?
| | Costa Rica | 1 | 2004 | 18 | 0.050 |
Why?
| | Carcinoma, Squamous Cell | 3 | 2015 | 642 | 0.050 |
Why?
| | Argentina | 1 | 2004 | 30 | 0.050 |
Why?
| | Spermatogonia | 1 | 2004 | 15 | 0.050 |
Why?
| | Stroke | 1 | 2013 | 1258 | 0.050 |
Why?
| | Observer Variation | 1 | 2025 | 355 | 0.050 |
Why?
| | Chile | 1 | 2004 | 26 | 0.050 |
Why?
| | Diet Surveys | 1 | 1984 | 91 | 0.050 |
Why?
| | Diet | 4 | 2003 | 1275 | 0.050 |
Why?
| | Tandem Repeat Sequences | 1 | 2004 | 22 | 0.050 |
Why?
| | No-Observed-Adverse-Effect Level | 1 | 2004 | 6 | 0.050 |
Why?
| | Bronchodilator Agents | 1 | 2005 | 183 | 0.050 |
Why?
| | Peru | 1 | 2004 | 62 | 0.050 |
Why?
| | Picornaviridae | 1 | 2004 | 18 | 0.050 |
Why?
| | Uganda | 1 | 2024 | 93 | 0.050 |
Why?
| | Electroencephalography | 1 | 2007 | 551 | 0.050 |
Why?
| | Mentors | 2 | 2003 | 219 | 0.050 |
Why?
| | Nose Diseases | 1 | 2004 | 17 | 0.050 |
Why?
| | Aircraft | 1 | 2004 | 23 | 0.050 |
Why?
| | Propylene Glycols | 1 | 2024 | 27 | 0.050 |
Why?
| | Shoulder Pain | 1 | 2024 | 36 | 0.050 |
Why?
| | Clinical Trials, Phase II as Topic | 1 | 2004 | 77 | 0.050 |
Why?
| | Ear Diseases | 1 | 2004 | 18 | 0.050 |
Why?
| | Aerospace Medicine | 1 | 2004 | 33 | 0.050 |
Why?
| | Sugars | 1 | 2024 | 41 | 0.050 |
Why?
| | Picornaviridae Infections | 1 | 2004 | 50 | 0.050 |
Why?
| | Saskatchewan | 1 | 2003 | 8 | 0.050 |
Why?
| | Shoulder | 1 | 2024 | 105 | 0.050 |
Why?
| | Nasal Mucosa | 1 | 2004 | 112 | 0.050 |
Why?
| | Fourier Analysis | 1 | 2003 | 41 | 0.050 |
Why?
| | Observation | 1 | 2003 | 54 | 0.050 |
Why?
| | Food | 1 | 1984 | 149 | 0.050 |
Why?
| | Decision Support Techniques | 1 | 2008 | 456 | 0.050 |
Why?
| | Chicago | 1 | 2003 | 61 | 0.050 |
Why?
| | Probability | 2 | 2003 | 312 | 0.050 |
Why?
| | Free Radical Scavengers | 4 | 2012 | 82 | 0.050 |
Why?
| | Wakefulness | 1 | 2004 | 169 | 0.050 |
Why?
| | Computing Methodologies | 1 | 2003 | 3 | 0.050 |
Why?
| | Maps as Topic | 1 | 2003 | 5 | 0.050 |
Why?
| | Phosphotyrosine | 2 | 2000 | 39 | 0.050 |
Why?
| | Coroners and Medical Examiners | 1 | 2022 | 8 | 0.050 |
Why?
| | Maternal-Fetal Exchange | 2 | 2015 | 169 | 0.050 |
Why?
| | Washington | 1 | 2003 | 147 | 0.050 |
Why?
| | Efficiency | 1 | 2003 | 104 | 0.050 |
Why?
| | Terminology as Topic | 1 | 1985 | 255 | 0.050 |
Why?
| | Genomics | 1 | 2008 | 836 | 0.050 |
Why?
| | Geographic Information Systems | 1 | 2003 | 46 | 0.050 |
Why?
| | Neoplasm Staging | 2 | 2021 | 1465 | 0.050 |
Why?
| | Income | 2 | 1994 | 202 | 0.050 |
Why?
| | Body Constitution | 1 | 2002 | 51 | 0.050 |
Why?
| | Steroids | 1 | 2003 | 160 | 0.050 |
Why?
| | Nitrosamines | 2 | 2012 | 9 | 0.050 |
Why?
| | Sleep Wake Disorders | 1 | 2006 | 302 | 0.050 |
Why?
| | Carbon Dioxide | 1 | 2004 | 242 | 0.050 |
Why?
| | Macrophages, Alveolar | 2 | 1997 | 368 | 0.050 |
Why?
| | Chi-Square Distribution | 2 | 2006 | 529 | 0.040 |
Why?
| | Epidemiologic Measurements | 1 | 2001 | 1 | 0.040 |
Why?
| | Chelating Agents | 2 | 1999 | 73 | 0.040 |
Why?
| | Toxins, Biological | 1 | 2001 | 12 | 0.040 |
Why?
| | Joint Instability | 1 | 2024 | 182 | 0.040 |
Why?
| | Peer Group | 1 | 2004 | 257 | 0.040 |
Why?
| | Invertebrates | 1 | 2001 | 24 | 0.040 |
Why?
| | Internet | 1 | 2006 | 700 | 0.040 |
Why?
| | France | 1 | 2021 | 40 | 0.040 |
Why?
| | Philadelphia | 2 | 1998 | 55 | 0.040 |
Why?
| | Sinusitis | 1 | 2004 | 229 | 0.040 |
Why?
| | Schizophrenia | 1 | 2025 | 446 | 0.040 |
Why?
| | Vitamin A | 3 | 1987 | 59 | 0.040 |
Why?
| | Patient Acceptance of Health Care | 1 | 1988 | 886 | 0.040 |
Why?
| | Likelihood Functions | 1 | 2001 | 143 | 0.040 |
Why?
| | Fishes | 1 | 2001 | 108 | 0.040 |
Why?
| | Food Chain | 1 | 2001 | 46 | 0.040 |
Why?
| | Germany | 1 | 2021 | 138 | 0.040 |
Why?
| | Treatment Outcome | 2 | 2008 | 11695 | 0.040 |
Why?
| | C-Reactive Protein | 1 | 2023 | 417 | 0.040 |
Why?
| | Population Dynamics | 1 | 2001 | 158 | 0.040 |
Why?
| | Drug Administration Schedule | 1 | 2002 | 783 | 0.040 |
Why?
| | Double-Blind Method | 2 | 2016 | 2029 | 0.040 |
Why?
| | Pilot Projects | 1 | 2006 | 1890 | 0.040 |
Why?
| | Postmenopause | 1 | 2002 | 391 | 0.040 |
Why?
| | Health Knowledge, Attitudes, Practice | 2 | 2010 | 1416 | 0.040 |
Why?
| | Mathematics | 1 | 2000 | 100 | 0.040 |
Why?
| | Respiratory Hypersensitivity | 1 | 2000 | 65 | 0.040 |
Why?
| | Stem Cells | 1 | 2004 | 627 | 0.040 |
Why?
| | Receptors, Progesterone | 1 | 2002 | 356 | 0.040 |
Why?
| | Drug Interactions | 2 | 2003 | 401 | 0.040 |
Why?
| | Chromosome Deletion | 2 | 1997 | 124 | 0.040 |
Why?
| | Confidence Intervals | 3 | 2009 | 333 | 0.040 |
Why?
| | Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 1 | 1999 | 44 | 0.040 |
Why?
| | Protein Synthesis Inhibitors | 1 | 1999 | 48 | 0.040 |
Why?
| | Smoking Water Pipes | 1 | 2019 | 9 | 0.040 |
Why?
| | Health Status Indicators | 2 | 2000 | 166 | 0.040 |
Why?
| | Culture Media | 1 | 1999 | 161 | 0.040 |
Why?
| | Bibliometrics | 1 | 1999 | 63 | 0.040 |
Why?
| | Religious Personnel | 1 | 2018 | 1 | 0.040 |
Why?
| | Mitogen-Activated Protein Kinases | 1 | 2000 | 292 | 0.040 |
Why?
| | Infant, Low Birth Weight | 1 | 1999 | 153 | 0.040 |
Why?
| | Fossil Fuels | 2 | 2001 | 10 | 0.040 |
Why?
| | Receptors, Estrogen | 1 | 2002 | 457 | 0.040 |
Why?
| | Bronchoalveolar Lavage Fluid | 2 | 1998 | 636 | 0.040 |
Why?
| | Heart Rate | 1 | 2002 | 855 | 0.040 |
Why?
| | Acquired Immunodeficiency Syndrome | 1 | 2000 | 235 | 0.030 |
Why?
| | Activities of Daily Living | 2 | 1993 | 441 | 0.030 |
Why?
| | Maternal Age | 1 | 1998 | 126 | 0.030 |
Why?
| | Acculturation | 1 | 2018 | 54 | 0.030 |
Why?
| | Copper | 1 | 1998 | 113 | 0.030 |
Why?
| | Anthropometry | 1 | 2018 | 200 | 0.030 |
Why?
| | DNA Adducts | 1 | 1997 | 16 | 0.030 |
Why?
| | Benzo(a)pyrene | 1 | 1997 | 8 | 0.030 |
Why?
| | Mice | 4 | 2008 | 18365 | 0.030 |
Why?
| | Lactation | 1 | 1998 | 192 | 0.030 |
Why?
| | Arizona | 2 | 2006 | 81 | 0.030 |
Why?
| | Interleukin-6 | 2 | 1998 | 780 | 0.030 |
Why?
| | Clinical Competence | 1 | 2025 | 1244 | 0.030 |
Why?
| | Stakeholder Participation | 1 | 2018 | 84 | 0.030 |
Why?
| | National Heart, Lung, and Blood Institute (U.S.) | 1 | 2017 | 103 | 0.030 |
Why?
| | HIV Seronegativity | 1 | 1996 | 29 | 0.030 |
Why?
| | Injury Severity Score | 1 | 2019 | 600 | 0.030 |
Why?
| | Marriage | 3 | 1987 | 122 | 0.030 |
Why?
| | Weight Loss | 1 | 2022 | 837 | 0.030 |
Why?
| | Multilevel Analysis | 1 | 2016 | 36 | 0.030 |
Why?
| | Mice, Inbred CBA | 1 | 1996 | 57 | 0.030 |
Why?
| | Body Weight | 1 | 2021 | 978 | 0.030 |
Why?
| | Chemical Industry | 1 | 1996 | 9 | 0.030 |
Why?
| | Social Support | 2 | 1993 | 652 | 0.030 |
Why?
| | Phospholipases A2 | 1 | 1996 | 79 | 0.030 |
Why?
| | Silicon Dioxide | 1 | 1997 | 121 | 0.030 |
Why?
| | New Zealand | 1 | 2016 | 54 | 0.030 |
Why?
| | Arachidonate 5-Lipoxygenase | 1 | 1996 | 36 | 0.030 |
Why?
| | Head and Neck Neoplasms | 1 | 2001 | 562 | 0.030 |
Why?
| | Acetylcysteine | 2 | 2012 | 139 | 0.030 |
Why?
| | Needs Assessment | 1 | 1999 | 404 | 0.030 |
Why?
| | Multicenter Studies as Topic | 1 | 1998 | 405 | 0.030 |
Why?
| | Government Agencies | 1 | 1995 | 14 | 0.030 |
Why?
| | Eicosanoids | 1 | 1996 | 58 | 0.030 |
Why?
| | Patient Protection and Affordable Care Act | 1 | 2016 | 103 | 0.030 |
Why?
| | Genotype | 2 | 2014 | 1835 | 0.030 |
Why?
| | Disease Models, Animal | 1 | 2006 | 4569 | 0.030 |
Why?
| | Enzyme Inhibitors | 1 | 1999 | 826 | 0.030 |
Why?
| | Africa, Central | 1 | 2015 | 6 | 0.030 |
Why?
| | Indians, Central American | 1 | 2015 | 6 | 0.030 |
Why?
| | Asia, Southeastern | 1 | 2015 | 13 | 0.030 |
Why?
| | Central America | 1 | 2015 | 25 | 0.030 |
Why?
| | Indians, South American | 1 | 2015 | 23 | 0.030 |
Why?
| | Microscopy, Electron | 1 | 1996 | 415 | 0.030 |
Why?
| | South Africa | 1 | 2016 | 261 | 0.030 |
Why?
| | Rats, Sprague-Dawley | 2 | 1998 | 2540 | 0.030 |
Why?
| | Educational Status | 2 | 1996 | 467 | 0.030 |
Why?
| | Demography | 2 | 2000 | 288 | 0.030 |
Why?
| | Neoplasms, Experimental | 1 | 1996 | 173 | 0.030 |
Why?
| | Carrier Proteins | 1 | 1999 | 737 | 0.030 |
Why?
| | Cell Transformation, Neoplastic | 1 | 1997 | 339 | 0.030 |
Why?
| | Homosexuality, Male | 1 | 1996 | 222 | 0.030 |
Why?
| | Random Allocation | 1 | 1995 | 363 | 0.030 |
Why?
| | Carbohydrate Sequence | 1 | 1994 | 28 | 0.030 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2021 | 1721 | 0.030 |
Why?
| | Small Cell Lung Carcinoma | 1 | 2015 | 119 | 0.030 |
Why?
| | Cytokines | 2 | 2003 | 2065 | 0.030 |
Why?
| | Breast Feeding | 1 | 1998 | 448 | 0.030 |
Why?
| | Animals, Newborn | 1 | 1997 | 902 | 0.030 |
Why?
| | Linkage Disequilibrium | 1 | 2014 | 247 | 0.030 |
Why?
| | Population Density | 1 | 1994 | 101 | 0.030 |
Why?
| | Occupations | 2 | 2000 | 51 | 0.020 |
Why?
| | Hydrocarbons | 1 | 1993 | 31 | 0.020 |
Why?
| | Mental Competency | 1 | 1993 | 26 | 0.020 |
Why?
| | Ecosystem | 1 | 2018 | 589 | 0.020 |
Why?
| | Patient Care Team | 1 | 1999 | 689 | 0.020 |
Why?
| | Fatty Acids | 1 | 1996 | 452 | 0.020 |
Why?
| | Health Services Needs and Demand | 1 | 2015 | 280 | 0.020 |
Why?
| | Membrane Proteins | 1 | 1999 | 1167 | 0.020 |
Why?
| | Family Health | 1 | 1994 | 191 | 0.020 |
Why?
| | Recombinant Proteins | 1 | 1996 | 1371 | 0.020 |
Why?
| | Ecology | 1 | 1994 | 121 | 0.020 |
Why?
| | Vital Statistics | 1 | 1992 | 5 | 0.020 |
Why?
| | Transportation of Patients | 1 | 1993 | 68 | 0.020 |
Why?
| | Heart Failure | 1 | 2006 | 2323 | 0.020 |
Why?
| | Cadmium | 1 | 2012 | 69 | 0.020 |
Why?
| | Molecular Sequence Data | 2 | 1994 | 2931 | 0.020 |
Why?
| | Biopsy | 1 | 2015 | 1077 | 0.020 |
Why?
| | Electric Impedance | 1 | 2012 | 111 | 0.020 |
Why?
| | Permeability | 1 | 2012 | 168 | 0.020 |
Why?
| | Genes, p53 | 1 | 1992 | 67 | 0.020 |
Why?
| | Genes, ras | 1 | 1992 | 96 | 0.020 |
Why?
| | Physical Fitness | 1 | 1993 | 209 | 0.020 |
Why?
| | Africa | 1 | 2012 | 116 | 0.020 |
Why?
| | Drug Evaluation | 1 | 2011 | 79 | 0.020 |
Why?
| | Alleles | 1 | 2014 | 881 | 0.020 |
Why?
| | Sick Leave | 1 | 2011 | 16 | 0.020 |
Why?
| | Safety | 1 | 1993 | 356 | 0.020 |
Why?
| | Colorado | 1 | 2021 | 4564 | 0.020 |
Why?
| | Otitis Media | 1 | 1994 | 181 | 0.020 |
Why?
| | Recreation | 1 | 2011 | 27 | 0.020 |
Why?
| | Quality of Life | 1 | 2003 | 3192 | 0.020 |
Why?
| | Survivors | 2 | 2004 | 520 | 0.020 |
Why?
| | HIV-1 | 1 | 2016 | 896 | 0.020 |
Why?
| | Macrophages | 1 | 1998 | 1511 | 0.020 |
Why?
| | Dichlorodiphenyldichloroethane | 1 | 2009 | 1 | 0.020 |
Why?
| | Disease Progression | 1 | 1998 | 2852 | 0.020 |
Why?
| | RNA, Messenger | 4 | 1998 | 2832 | 0.020 |
Why?
| | Coffee | 1 | 2009 | 15 | 0.020 |
Why?
| | False Negative Reactions | 1 | 2009 | 61 | 0.020 |
Why?
| | Mass Media | 1 | 2010 | 41 | 0.020 |
Why?
| | Health Services | 1 | 1990 | 115 | 0.020 |
Why?
| | Reactive Oxygen Species | 1 | 2012 | 621 | 0.020 |
Why?
| | False Positive Reactions | 1 | 2009 | 122 | 0.020 |
Why?
| | Thorium | 1 | 1989 | 2 | 0.020 |
Why?
| | Ether | 1 | 2009 | 8 | 0.020 |
Why?
| | Radium | 1 | 1989 | 4 | 0.020 |
Why?
| | Metallurgy | 1 | 1989 | 9 | 0.020 |
Why?
| | Methylene Chloride | 1 | 2009 | 5 | 0.020 |
Why?
| | Early Detection of Cancer | 1 | 2014 | 466 | 0.020 |
Why?
| | Colorectal Neoplasms | 2 | 1996 | 848 | 0.020 |
Why?
| | Rectal Neoplasms | 1 | 1990 | 158 | 0.020 |
Why?
| | Gene Expression Regulation | 1 | 1998 | 2609 | 0.020 |
Why?
| | Culture | 1 | 2010 | 125 | 0.020 |
Why?
| | Neuropsychological Tests | 1 | 1993 | 1137 | 0.020 |
Why?
| | Taiwan | 1 | 2008 | 46 | 0.020 |
Why?
| | Lipid Metabolism | 1 | 1992 | 528 | 0.020 |
Why?
| | Death Certificates | 1 | 1988 | 32 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2016 | 2925 | 0.020 |
Why?
| | Pyridines | 1 | 2012 | 605 | 0.020 |
Why?
| | Cell Differentiation | 1 | 1996 | 2050 | 0.020 |
Why?
| | Secondary Prevention | 1 | 2010 | 255 | 0.020 |
Why?
| | Industrial Waste | 1 | 2008 | 6 | 0.020 |
Why?
| | Colonic Neoplasms | 1 | 1990 | 260 | 0.020 |
Why?
| | Pregnancy Complications | 1 | 1994 | 592 | 0.020 |
Why?
| | Liver | 1 | 1997 | 1888 | 0.020 |
Why?
| | Ovalbumin | 1 | 2008 | 190 | 0.020 |
Why?
| | Welding | 1 | 1987 | 2 | 0.020 |
Why?
| | Government Programs | 1 | 2008 | 26 | 0.020 |
Why?
| | Paint | 1 | 1987 | 9 | 0.020 |
Why?
| | Texas | 1 | 1988 | 278 | 0.020 |
Why?
| | Risk Reduction Behavior | 1 | 2009 | 226 | 0.020 |
Why?
| | Forced Expiratory Flow Rates | 1 | 1987 | 10 | 0.020 |
Why?
| | Schools | 1 | 2011 | 453 | 0.020 |
Why?
| | Peak Expiratory Flow Rate | 1 | 1987 | 25 | 0.020 |
Why?
| | Conservation of Energy Resources | 1 | 2007 | 3 | 0.020 |
Why?
| | Physical Examination | 1 | 1988 | 240 | 0.020 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2014 | 2147 | 0.020 |
Why?
| | Behavior Therapy | 1 | 2010 | 299 | 0.020 |
Why?
| | Calcium | 1 | 2012 | 1184 | 0.020 |
Why?
| | Radiation Monitoring | 1 | 1986 | 16 | 0.010 |
Why?
| | Massachusetts | 1 | 2006 | 180 | 0.010 |
Why?
| | Attitude | 1 | 1988 | 261 | 0.010 |
Why?
| | Air Conditioning | 1 | 2006 | 6 | 0.010 |
Why?
| | HIV | 1 | 2007 | 250 | 0.010 |
Why?
| | Medical History Taking | 1 | 1986 | 117 | 0.010 |
Why?
| | Oxidative Stress | 1 | 2012 | 1339 | 0.010 |
Why?
| | Arousal | 1 | 2006 | 157 | 0.010 |
Why?
| | Antiretroviral Therapy, Highly Active | 1 | 2007 | 278 | 0.010 |
Why?
| | Physicians | 1 | 1994 | 940 | 0.010 |
Why?
| | Rural Population | 2 | 1987 | 650 | 0.010 |
Why?
| | Statistics as Topic | 1 | 1986 | 284 | 0.010 |
Why?
| | Electronic Health Records | 1 | 2013 | 1177 | 0.010 |
Why?
| | beta Carotene | 1 | 1984 | 20 | 0.010 |
Why?
| | Carotenoids | 1 | 1984 | 48 | 0.010 |
Why?
| | Dementia | 1 | 1988 | 304 | 0.010 |
Why?
| | Nitrogen Oxides | 1 | 2004 | 54 | 0.010 |
Why?
| | X-Rays | 1 | 2003 | 31 | 0.010 |
Why?
| | Pneumoconiosis | 1 | 1984 | 20 | 0.010 |
Why?
| | Heart Conduction System | 1 | 2004 | 95 | 0.010 |
Why?
| | Biophysical Phenomena | 1 | 2003 | 68 | 0.010 |
Why?
| | Population | 1 | 2003 | 30 | 0.010 |
Why?
| | Gamma Rays | 1 | 2003 | 56 | 0.010 |
Why?
| | Biophysics | 1 | 2003 | 74 | 0.010 |
Why?
| | Oxyhemoglobins | 1 | 2003 | 28 | 0.010 |
Why?
| | Cell Line | 2 | 1998 | 2882 | 0.010 |
Why?
| | Mothers | 1 | 2009 | 775 | 0.010 |
Why?
| | Databases, Factual | 1 | 2008 | 1486 | 0.010 |
Why?
| | Training Support | 1 | 2002 | 36 | 0.010 |
Why?
| | Blood Pressure | 1 | 2009 | 1769 | 0.010 |
Why?
| | Receptors, Phospholipase A2 | 1 | 2001 | 1 | 0.010 |
Why?
| | Pharyngeal Neoplasms | 1 | 2001 | 4 | 0.010 |
Why?
| | Annexin A5 | 1 | 2001 | 21 | 0.010 |
Why?
| | Interleukin-3 | 1 | 2001 | 23 | 0.010 |
Why?
| | Vital Capacity | 1 | 2003 | 290 | 0.010 |
Why?
| | Polymerase Chain Reaction | 2 | 1997 | 1054 | 0.010 |
Why?
| | Oxidants, Photochemical | 1 | 2001 | 8 | 0.010 |
Why?
| | Food Contamination | 1 | 2001 | 56 | 0.010 |
Why?
| | Pancreatic Neoplasms | 1 | 2009 | 927 | 0.010 |
Why?
| | Lysophospholipids | 1 | 2001 | 77 | 0.010 |
Why?
| | Disease Transmission, Infectious | 1 | 2001 | 69 | 0.010 |
Why?
| | Mouth Neoplasms | 1 | 2001 | 90 | 0.010 |
Why?
| | Isoenzymes | 1 | 2001 | 299 | 0.010 |
Why?
| | Mutation | 1 | 1992 | 4099 | 0.010 |
Why?
| | Parents | 1 | 1989 | 1403 | 0.010 |
Why?
| | Immunoenzyme Techniques | 1 | 2000 | 200 | 0.010 |
Why?
| | Melanoma | 2 | 1986 | 761 | 0.010 |
Why?
| | Fungi | 1 | 2001 | 161 | 0.010 |
Why?
| | Extracellular Matrix | 1 | 2003 | 553 | 0.010 |
Why?
| | Reference Values | 1 | 2000 | 798 | 0.010 |
Why?
| | Ceruloplasmin | 1 | 1998 | 9 | 0.010 |
Why?
| | Boston | 1 | 1978 | 92 | 0.010 |
Why?
| | Fuel Oils | 1 | 1998 | 2 | 0.010 |
Why?
| | Enzyme Activation | 1 | 2000 | 768 | 0.010 |
Why?
| | Histocytochemistry | 1 | 1998 | 79 | 0.010 |
Why?
| | Protein Biosynthesis | 1 | 2001 | 458 | 0.010 |
Why?
| | Utah | 1 | 1998 | 81 | 0.010 |
Why?
| | Receptors, Transferrin | 1 | 1998 | 28 | 0.010 |
Why?
| | Cell Survival | 1 | 2001 | 1098 | 0.010 |
Why?
| | Intercellular Adhesion Molecule-1 | 1 | 1998 | 138 | 0.010 |
Why?
| | Thiourea | 1 | 1997 | 41 | 0.010 |
Why?
| | Autoradiography | 1 | 1997 | 65 | 0.010 |
Why?
| | Software | 1 | 2003 | 692 | 0.010 |
Why?
| | Blotting, Western | 1 | 2000 | 1187 | 0.010 |
Why?
| | Respiratory Mucosa | 1 | 2000 | 322 | 0.010 |
Why?
| | Intubation, Intratracheal | 1 | 2000 | 320 | 0.010 |
Why?
| | Interferons | 1 | 1998 | 188 | 0.010 |
Why?
| | Sputum | 1 | 1978 | 308 | 0.010 |
Why?
| | Microsatellite Repeats | 1 | 1997 | 157 | 0.010 |
Why?
| | Heterozygote | 1 | 1997 | 315 | 0.010 |
Why?
| | Comorbidity | 1 | 2001 | 1660 | 0.010 |
Why?
| | Epithelium | 1 | 1997 | 314 | 0.010 |
Why?
| | Interleukin-8 | 1 | 1997 | 271 | 0.010 |
Why?
| | Age of Onset | 1 | 1998 | 551 | 0.010 |
Why?
| | Heart Defects, Congenital | 1 | 2004 | 914 | 0.010 |
Why?
| | Transfection | 1 | 1998 | 940 | 0.010 |
Why?
| | Protein Binding | 1 | 2001 | 2276 | 0.010 |
Why?
| | Skin Neoplasms | 1 | 1982 | 847 | 0.010 |
Why?
| | Transcription, Genetic | 1 | 2001 | 1496 | 0.010 |
Why?
| | Polymorphism, Genetic | 1 | 1997 | 612 | 0.010 |
Why?
| | Pacific Islands | 1 | 1994 | 5 | 0.010 |
Why?
| | West Virginia | 1 | 1993 | 9 | 0.010 |
Why?
| | Promoter Regions, Genetic | 1 | 1998 | 1258 | 0.010 |
Why?
| | Apoptosis | 1 | 2001 | 2430 | 0.010 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 1997 | 1217 | 0.010 |
Why?
| | Platelet Activating Factor | 1 | 1992 | 49 | 0.010 |
Why?
| | Prostaglandins | 1 | 1992 | 94 | 0.010 |
Why?
| | Primary Prevention | 1 | 1994 | 220 | 0.010 |
Why?
| | Respiratory Function Tests | 1 | 1994 | 547 | 0.010 |
Why?
| | Codon | 1 | 1992 | 94 | 0.010 |
Why?
| | DNA, Neoplasm | 1 | 1992 | 164 | 0.010 |
Why?
| | DNA | 1 | 1998 | 1464 | 0.010 |
Why?
| | In Vitro Techniques | 1 | 1992 | 1048 | 0.010 |
Why?
| | Base Sequence | 1 | 1992 | 2191 | 0.000 |
Why?
| | Cognition | 1 | 1996 | 1269 | 0.000 |
Why?
| | Carcinoma, Bronchogenic | 1 | 1986 | 20 | 0.000 |
Why?
| | Eye Neoplasms | 1 | 1986 | 30 | 0.000 |
Why?
| | Carcinoma, Small Cell | 1 | 1987 | 173 | 0.000 |
Why?
| | Retinoblastoma | 1 | 1986 | 42 | 0.000 |
Why?
| | Feasibility Studies | 1 | 1990 | 1095 | 0.000 |
Why?
| | Lymphoma | 1 | 1986 | 233 | 0.000 |
Why?
| | Leukemia | 1 | 1986 | 245 | 0.000 |
Why?
| | Self Disclosure | 1 | 1984 | 62 | 0.000 |
Why?
| | Neck | 1 | 1982 | 108 | 0.000 |
Why?
| | Head | 1 | 1982 | 120 | 0.000 |
Why?
|
|
Samet's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|